TrialMultiple sclerosis (Houndmills, Basingstoke, England)2012

Pre-specified subgroup analyses of a placebo-controlled phase III trial (TEMSO) of oral teriflunomide in relapsing multiple sclerosis.

Aaron E Miller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.